News | March 3, 2021

Andelyn Biosciences Breaks Ground On Facility, Strengthens Columbus As Biotech Hub

Andelyn New Facility Rendering

Andelyn Biosciences is already a world leader in gene therapy development and manufacturing thanks to foundational gene therapy research from its affiliate partner Nationwide Children's Hospital.

Now, Andelyn has broken ground on a new 185,000-square-foot facility – slated to open in 2022 – that will expand its gene therapy manufacturing capabilities and Columbus, Ohio’s pioneering biotech reputation.

Andelyn will create more than 200 new jobs (in addition to a baseline of more than 100 full-time employees) and invest more than $100 million as a new gene therapy contract development and manufacturing organization (CDMO) in Columbus. The facility will add a critical element to central Ohio’s cell and gene therapy ecosystem as world-class researchers, biotechnology facilities and a growing investor base have created a hub of gene therapy excellence. The project is being assisted with a $5 million JobsOhio Research and Development Center Grant.

To make Andelyn Biosciences possible, Nationwide Children’s is working with key local partners, including JobsOhio, the City of Columbus, Columbus City Schools, One Columbus, The Columbus Partnership and Rev1 Ventures to create jobs and expand central Ohio’s influence in the biotechnology sector.

“This is an exciting time for Andelyn Biosciences as we are one step closer to offering a wider portfolio of capabilities and services that will ultimately be game changing for our clients,” said Mayo Pujols, chief executive officer of Andelyn Biosciences. “I want to thank all of our local partners for their support. Together, we are working to serve many patients around the world who need life-saving therapies.”

Andelyn Biosciences is a for-profit manufacturer, but its unique business model will lead to reinvestment into pioneering research conducted at the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s.

The land lease for Andelyn Biosciences has been executed with SciTech. The architect for the project is CE&IC, and the contractor is Gilbane.


Source: Andelyn Biosciences